The soluble ectodomain has been implicated as a decoy for ligand–receptor interactions in PTPRS signaling, with potential therapeutic applications in diseases such as cancer, Alzheimer’s disease, stroke, traumatic brain injury, and rheumatoid arthritis. The gene discussed is PTPRS; the disease is brain injury.